JP2006514945A5 - - Google Patents

Download PDF

Info

Publication number
JP2006514945A5
JP2006514945A5 JP2004558793A JP2004558793A JP2006514945A5 JP 2006514945 A5 JP2006514945 A5 JP 2006514945A5 JP 2004558793 A JP2004558793 A JP 2004558793A JP 2004558793 A JP2004558793 A JP 2004558793A JP 2006514945 A5 JP2006514945 A5 JP 2006514945A5
Authority
JP
Japan
Prior art keywords
contrast agent
agent according
contrast
antagonist
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004558793A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006514945A (ja
Filing date
Publication date
Priority claimed from GBGB0228490.9A external-priority patent/GB0228490D0/en
Application filed filed Critical
Publication of JP2006514945A publication Critical patent/JP2006514945A/ja
Publication of JP2006514945A5 publication Critical patent/JP2006514945A5/ja
Pending legal-status Critical Current

Links

JP2004558793A 2002-12-06 2003-12-05 循環器疾患造影用の標識マクロファージスカベンジャー受容体拮抗薬 Pending JP2006514945A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0228490.9A GB0228490D0 (en) 2002-12-06 2002-12-06 Novel imaging compounds
PCT/GB2003/005319 WO2004052357A1 (en) 2002-12-06 2003-12-05 Labeled macrophage scavenger receptor antagonists for imaging cardiovascular diseases

Publications (2)

Publication Number Publication Date
JP2006514945A JP2006514945A (ja) 2006-05-18
JP2006514945A5 true JP2006514945A5 (https=) 2007-02-08

Family

ID=9949200

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004558793A Pending JP2006514945A (ja) 2002-12-06 2003-12-05 循環器疾患造影用の標識マクロファージスカベンジャー受容体拮抗薬

Country Status (10)

Country Link
US (1) US20060239915A1 (https=)
EP (1) EP1567141A1 (https=)
JP (1) JP2006514945A (https=)
CN (1) CN1744890A (https=)
AU (1) AU2003292384B2 (https=)
CA (1) CA2508663A1 (https=)
GB (1) GB0228490D0 (https=)
NO (1) NO20052633L (https=)
RU (1) RU2005116983A (https=)
WO (1) WO2004052357A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7886497B2 (en) 2003-12-02 2011-02-15 Valinge Innovation Ab Floorboard, system and method for forming a flooring, and a flooring formed thereof
GB0428020D0 (en) 2004-12-22 2005-01-26 Amersham Health As Stabilisation of radiopharmaceutical precursors
WO2006077901A1 (ja) * 2005-01-20 2006-07-27 Shionogi & Co., Ltd. Ctgf発現阻害剤
MX2010005122A (es) * 2007-11-07 2010-08-18 Ge Healthcare Bv Estabilizacion de radiofarmaceuticos.
US11725395B2 (en) 2009-09-04 2023-08-15 Välinge Innovation AB Resilient floor
ES2985671T3 (es) 2009-09-04 2024-11-06 Vaelinge Innovation Ab Suelo elástico
JP6105587B2 (ja) 2011-08-29 2017-04-05 セラロック、イノベーション、アクチボラグ フロアパネル用機械式係止システム
EP3656944A1 (en) 2013-03-25 2020-05-27 Välinge Innovation AB Floorboards provided with a mechanical locking system and a method to produce such a locking system
EP4140991B1 (en) * 2018-06-01 2024-05-15 Promega Corporation Inhibitors of oplophorus luciferase-derived bioluminescent complexes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5820873A (en) * 1994-09-30 1998-10-13 The University Of British Columbia Polyethylene glycol modified ceramide lipids and liposome uses thereof
WO2000078145A1 (en) * 1999-06-24 2000-12-28 Smithkline Beecham Corporation Macrophage scavenger receptor antagonists
WO2001098264A1 (en) * 2000-06-21 2001-12-27 Smithkline Beecham Corporation Macrophage scavenger receptor antagonists
AU2002254000A1 (en) * 2001-02-23 2002-09-12 Bristol-Myers Squibb Pharma Company Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque

Similar Documents

Publication Publication Date Title
Xia et al. Liposome-based probes for molecular imaging: from basic research to the bedside
Santos et al. Nanostructured porous silicon in preclinical imaging: moving from bench to bedside
US11672866B2 (en) Osteotropic nanoparticles for prevention or treatment of bone metastases
DE69824842T2 (de) Kontrastmittel, die auf angiogenese-rezeptoren zielen
Wang et al. A new optical and nuclear dual-labeled imaging agent targeting interleukin 11 receptor alpha-chain
JP2006514945A5 (https=)
Zheng et al. Quantitative CT imaging of the spatial and temporal distribution of liposomes in a rabbit tumor model
RU2007104096A (ru) Способ лечения аллергии или вызываемых аллергией поражений дыхательных путей и фармацевтическая композиция
JP2010513441A5 (https=)
Criscione et al. Development and application of a multimodal contrast agent for SPECT/CT hybrid imaging
RU2008150310A (ru) Производные ацетамида 2-арилпиразола[1,5 альфа] пиримидин-3-ила в качестве лигандов для белка-транслокатора(18кда)
Liu et al. Efficient construction of PET/fluorescence probe based on sarcophagine cage: an opportunity to integrate diagnosis with treatment
Zhang et al. Sequential SPECT and NIR-II imaging of tumor and sentinel lymph node metastasis for diagnosis and image-guided surgery
US20180022768A1 (en) Radioactive phospholipid metal chelates for cancer imaging and therapy
US20080228069A1 (en) Novel Differential Imaging Method
JP2005523941A5 (https=)
Huang et al. Recent advances in PAMAM dendrimer-based CT contrast agents for molecular imaging and theranostics of cancer
Liu et al. A non-intrusive evaluation method for tumor-targeting characteristics of nanomedicines based on in vivo near-infrared fluorescence imaging
RU2005116983A (ru) Меченые антагонисты фагоцитарных рецепторов макрофагов для визуализации сердечно-сосудистых заболеваний
JP2009538894A5 (https=)
US11052163B2 (en) Homing agents
Mushtaq et al. Efficient and site-specific 125I-radioiodination of bioactive molecules using oxidative condensation reaction
CN101151053A (zh) 杂合无机纳米颗粒、其使用和制备方法
US11266755B2 (en) Development and application of tumor diagnostic radioactive probe targeting folic acid receptor
JP2006505550A5 (https=)